ESSA Pharma to Present at Upcoming March Investor Conferences

Rhea-AI Summary

ESSA Pharma Inc. (NASDAQ: EPIX) announced that President and CEO Dr. David R. Parkinson will present at three virtual investor conferences in March 2021. The conferences include the Cowen 41st Annual Health Care Conference on March 4 at 12:10 p.m. ET, the H.C. Wainwright Annual Global Life Sciences Conference on March 9 at 7:00 a.m. ET, and the Oppenheimer 31st Annual Healthcare Conference on March 18 at 11:20 a.m. ET. Webcasts will be accessible on the ESSA website and archived for 90 days after each event.

HOUSTON, Texas and VANCOUVER, Canada, Feb. 25, 2021 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that Dr. David R. Parkinson, President and Chief Executive Officer of ESSA Pharma, will be presenting and hosting one-on-one meetings with investors at three upcoming virtual investor conferences. Peter Virsik, ESSA's Chief Operating Officer, and David S. Wood, ESSA's Chief Financial Officer, will also be available for one-on-one meetings.

Presentation Details:

Event: Cowen 41st Annual Health Care Conference
Date: Thursday, March 4, 2021
Time: 12:10 p.m. ET

Event: H.C. Wainwright Annual Global Life Sciences Conference
Date: Tuesday, March 9, 2021
Time (on-demand): 7:00 a.m. ET

Event: Oppenheimer 31st Annual Healthcare Conference
Date: Thursday, March 18, 2021
Time: 11:20 a.m. ET

Webcasts of the events can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. Following the events, the webcasts will be archived on the ESSA website for 90 days.

About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com and follow us on Twitter under @ESSAPharma.

View original content:http://www.prnewswire.com/news-releases/essa-pharma-to-present-at-upcoming-march-investor-conferences-301235830.html

SOURCE ESSA Pharma Inc

FAQ

What is the schedule for ESSA Pharma's upcoming investor conferences?

ESSA Pharma will present at three conferences: Cowen 41st Annual Health Care Conference on March 4, 2021, at 12:10 p.m. ET, H.C. Wainwright Annual Global Life Sciences Conference on March 9, 2021, at 7:00 a.m. ET, and Oppenheimer 31st Annual Healthcare Conference on March 18, 2021, at 11:20 a.m. ET.

Who will represent ESSA Pharma at the March investor conferences?

Dr. David R. Parkinson, President and CEO, will represent ESSA Pharma, along with COO Peter Virsik and CFO David S. Wood for one-on-one meetings.

Where can I access the webcasts for ESSA Pharma's investor conferences?

Webcasts for the investor conferences can be accessed on the ESSA Pharma website under the Investors/Events & Presentations section.

How long will the webcasts of ESSA Pharma's investor conferences be available?

The webcasts will be archived on the ESSA Pharma website for 90 days following each event.